March 10, 2016 when SeeThruEquity coverage began, AVDX pps was 0.40 12 months later March 10, 2017 it was 0.23 NOW it's 0.077 So much for the 2.97 target price. NEW YORK, NY / ACCESSWIRE / March 10, 2016 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced it has initiated coverage on Avant Diagnostics, Inc. (AVDX) with a price target of $2.97. "We are initiating coverage with a 12-month price target of $2.97 per share." https://finance.yahoo.com/news/seethruequity-initiates-coverage-avant-diagnostics-181400469.html